Gilead Sciences
GILD
#134
Rank
โ‚ฌ142.46 B
Marketcap
114,74ย โ‚ฌ
Share price
4.21%
Change (1 day)
20.93%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of March 2026 : โ‚ฌ6.68 Billion

According to Gilead Sciences's latest financial reports the company has โ‚ฌ6.68 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ8.18 B-26.39%
2024-12-31โ‚ฌ11.11 B69.17%
2023-12-31โ‚ฌ6.57 B10.39%
2022-12-31โ‚ฌ5.95 B3.39%
2021-12-31โ‚ฌ5.75 B-4.41%
2020-12-31โ‚ฌ6.02 B-72.29%
2019-12-31โ‚ฌ21.73 B-17.35%
2018-12-31โ‚ฌ26.30 B23.71%
2017-12-31โ‚ฌ21.26 B88.01%
2016-12-31โ‚ฌ11.30 B-15.35%
2015-12-31โ‚ฌ13.35 B60.42%
2014-12-31โ‚ฌ8.32 B439.42%
2013-12-31โ‚ฌ1.54 B9.66%
2012-12-31โ‚ฌ1.40 B-81.53%
2011-12-31โ‚ฌ7.62 B383.17%
2010-12-31โ‚ฌ1.57 B36.42%
2009-12-31โ‚ฌ1.15 B-9.68%
2008-12-31โ‚ฌ1.28 B59.52%
2007-12-31โ‚ฌ0.80 B13.05%
2006-12-31โ‚ฌ0.71 B-63.61%
2005-12-31โ‚ฌ1.95 B111.03%
2004-12-31โ‚ฌ0.92 B64.63%
2003-12-31โ‚ฌ0.56 B-37.71%
2002-12-31โ‚ฌ0.90 B36.6%
2001-12-31โ‚ฌ0.65 B21.22%
2000-12-31โ‚ฌ0.54 B86.09%
1999-12-31โ‚ฌ0.29 B243.39%
1998-12-31โ‚ฌ85.19 M215.94%
1997-12-31โ‚ฌ26.96 M-75.76%
1996-12-31โ‚ฌ0.11 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ19.27 B 188.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ11.42 B 71.07%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ8.20 B 22.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ4.61 B-30.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ10.52 B 57.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.74 B-43.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.00 B-84.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚ฌ6.33 B-5.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ4.98 B-25.40%๐Ÿ‡บ๐Ÿ‡ธ USA